canakinumab April 12, 2017 canakinumab Trade Name Ilaris Orphan Indication Cryopyrin-associated periodic syndromes USA Market Approval USA USA Designation Date 2007-12-18 00:00:00 Sponsor Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936
